+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

3D Cell Culture Market Size, Share & Trends Analysis Report by Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4599544
Description Jump to:
The global 3D cell culture market is anticipated to reach USD 3.21 billion by 2030 and is anticipated to expand at a CAGR of 11.22% during 2024 to 2030. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights

  • The scaffold-based technology segment dominated the market in 2023 with a revenue share of 48.94% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
  • Stem cell research & tissue engineering held the largest share in 2023, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
  • In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share in 2023. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
  • North America region dominated the global market in 2023 with a revenue share of 38.97%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Technology Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for organ transplantation & tissue engineering
3.2.1.2. Technological advancements in scaffold free technology
3.2.1.3. Rise in investments and R&D funding for cell-based research
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with implementation
3.2.2.2. Lack of compatibility and consistency
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. 3D Cell Culture Market: Technology Movement Analysis
4.2. Scaffold Based
4.2.1. Scaffold based market estimates and forecasts, 2018-2030 (USD Million)
4.2.2. Hydrogels
4.2.2.1. Hydrogels market estimates and forecasts, 2018-2030 (USD Million)
4.2.3. Polymeric Scaffolds
4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018-2030 (USD Million)
4.2.4. Micropatterned Surface Microplates
4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018-2030 (USD Million)
4.2.5. Nanofiber Based Scaffolds
4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018-2030 (USD Million)
4.3. Scaffold Free
4.3.1. Scaffold free market estimates and forecasts, 2018-2030 (USD Million)
4.3.2. Hanging Drop Microplates
4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018-2030 (USD Million)
4.3.3. Spheroid Microplates with ULA coating
4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018-2030 (USD Million)
4.3.4. Magnetic Levitation
4.3.4.1. Magnetic levitation market estimates and forecasts, 2018-2030 (USD Million)
4.4. Bioreactors
4.4.1. Bioreactors market estimates and forecasts, 2018-2030 (USD Million)
4.5. Microfluidics
4.5.1. Microfluidics market estimates and forecasts, 2018-2030 (USD Million)
4.6. Bioprinting
4.6.1. Bioprinting market estimates and forecasts, 2018-2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. 3D Cell Culture Market: Application Movement Analysis
5.2. Cancer Research
5.2.1. Cancer research market estimates and forecasts, 2018-2030 (USD Million)
5.3. Stem Cell Research & Tissue Engineering
5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018-2030 (USD Million)
5.4. Drug Development & Toxicity Testing
5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018-2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. 3D Cell Culture Market: End-Use Movement Analysis
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018-2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & research institutes market estimates and forecasts, 2018-2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts, 2018-2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. 3D Cell Culture Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America 3D Cell Culture, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. 3D Cell Culture, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada 3D Cell Culture, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe 3D Cell Culture, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. UK 3D Cell Culture, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. Germany 3D Cell Culture, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France 3D Cell Culture, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy 3D Cell Culture, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain 3D Cell Culture, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark 3D Cell Culture, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden 3D Cell Culture, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway 3D Cell Culture, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific 3D Cell Culture, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan 3D Cell Culture, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China 3D Cell Culture, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India 3D Cell Culture, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. Australia 3D Cell Culture, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Thailand 3D Cell Culture, 2018-2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. South Korea 3D Cell Culture, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America 3D Cell Culture, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil 3D Cell Culture, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Mexico 3D Cell Culture, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Target Disease Prevalence
7.5.4.4. Argentina 3D Cell Culture, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA 3D Cell Culture, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa 3D Cell Culture, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia 3D Cell Culture, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE 3D Cell Culture, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait 3D Cell Culture, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PromoCell GmbH
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Corning Incorporated
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Avantor, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Tecan Trading AG
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. REPROCELL Inc.
8.4.8.1. Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. CN Bio Innovations Ltd.
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Lena Biosciences
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global 3D cell culture market, by region, 2018-2030 (USD Million)
Table 3 North America 3D cell culture market, by country, 2018-2030 (USD Million)
Table 4 North America 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 5 North America 3D cell culture market, by application, 2018-2030 (USD Million)
Table 6 North America 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 7 U.S. 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 8 U.S. 3D cell culture market, by application, 2018-2030 (USD Million)
Table 9 U.S. 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 10 Canada 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 11 Canada 3D cell culture market, by application, 2018-2030 (USD Million)
Table 12 Canada 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 13 Europe 3D cell culture market, by country, 2018-2030 (USD Million)
Table 14 Europe 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 15 Europe 3D cell culture market, by application, 2018-2030 (USD Million)
Table 16 Europe 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 17 Germany 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 18 Germany 3D cell culture market, by application, 2018-2030 (USD Million)
Table 19 Germany 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 20 UK 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 21 UK 3D cell culture market, by application, 2018-2030 (USD Million)
Table 22 UK 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 23 France 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 24 France 3D cell culture market, by application, 2018-2030 (USD Million)
Table 25 France 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 26 Italy 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 27 Italy 3D cell culture market, by application, 2018-2030 (USD Million)
Table 28 Italy 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 29 Spain 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 30 Spain 3D cell culture market, by application, 2018-2030 (USD Million)
Table 31 Spain 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 32 Denmark 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 33 Denmark 3D cell culture market, by application, 2018-2030 (USD Million)
Table 34 Denmark 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 35 Sweden 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 36 Sweden 3D cell culture market, by application, 2018-2030 (USD Million)
Table 37 Sweden 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 38 Norway 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 39 Norway 3D cell culture market, by application, 2018-2030 (USD Million)
Table 40 Norway 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 41 Asia-Pacific 3D cell culture market, by country, 2018-2030 (USD Million)
Table 42 Asia-Pacific 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 43 Asia-Pacific 3D cell culture market, by application, 2018-2030 (USD Million)
Table 44 Asia-Pacific 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 45 China 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 46 China 3D cell culture market, by application, 2018-2030 (USD Million)
Table 47 China 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 48 Japan 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 49 Japan 3D cell culture market, by application, 2018-2030 (USD Million)
Table 50 Japan 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 51 India 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 52 India 3D cell culture market, by application, 2018-2030 (USD Million)
Table 53 India 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 54 South Korea 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 55 South Korea 3D cell culture market, by application, 2018-2030 (USD Million)
Table 56 South Korea 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 57 Australia 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 58 Australia 3D cell culture market, by application, 2018-2030 (USD Million)
Table 59 Australia 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 60 Thailand 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 61 Thailand 3D cell culture market, by application, 2018-2030 (USD Million)
Table 62 Thailand 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 63 Latin America 3D cell culture market, by country, 2018-2030 (USD Million)
Table 64 Latin America 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 65 Latin America 3D cell culture market, by application, 2018-2030 (USD Million)
Table 66 Latin America 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 67 Brazil 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 68 Brazil 3D cell culture market, by application, 2018-2030 (USD Million)
Table 69 Brazil 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 70 Mexico 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 71 Mexico 3D cell culture market, by application, 2018-2030 (USD Million)
Table 72 Mexico 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 73 Argentina 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 74 Argentina 3D cell culture market, by application, 2018-2030 (USD Million)
Table 75 Argentina 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 76 MEA 3D cell culture market, by country, 2018-2030 (USD Million)
Table 77 MEA 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 78 MEA 3D cell culture market, by application, 2018-2030 (USD Million)
Table 79 MEA 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 80 South Africa 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 81 South Africa 3D cell culture market, by application, 2018-2030 (USD Million)
Table 82 South Africa 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 83 Saudi Arabia 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 84 Saudi Arabia 3D cell culture market, by application, 2018-2030 (USD Million)
Table 85 Saudi Arabia 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 86 UAE 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 87 UAE 3D cell culture market, by application, 2018-2030 (USD Million)
Table 88 UAE 3D cell culture market, by end-use, 2018-2030 (USD Million)
Table 89 Kuwait 3D cell culture market, by technology, 2018-2030 (USD Million)
Table 90 Kuwait 3D cell culture market, by application, 2018-2030 (USD Million)
Table 91 Kuwait 3D cell culture market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 3D cell culture market: market outlook
Fig. 9 Parent market outlook
Fig. 10 3D cell culture market driver impact
Fig. 11 3D cell culture market restraint impact
Fig. 12 3D cell culture market: technology outlook and key takeaways
Fig. 13 3D cell culture market: technology movement analysis
Fig. 14 Scaffold based market estimates and forecast, 2018-2030 (USD Million)
Fig. 15 Hydrogels market estimates and forecast, 2018-2030 (USD Million)
Fig. 16 Polymeric scaffolds market estimates and forecast, 2018-2030 (USD Million)
Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018-2030 (USD Million)
Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018-2030 (USD Million)
Fig. 19 Scaffold free market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Hanging drop microplates market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Magnetic levitation market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Bioreactors market estimates and forecast, 2018-2030 (USD Million)
Fig. 24 Microfluidics market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 Bioprinting market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 3D cell culture market: application outlook and key takeaways
Fig. 27 3D cell culture market: application movement analysis
Fig. 28 Cancer research market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018-2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 3D cell culture market: end-use outlook and key takeaways
Fig. 33 3D cell culture market: end-use movement analysis
Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Academic & research institutes market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Hospitals market estimates and forecasts,2018-2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 North America 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Europe 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 UK 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Germany 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 France 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Italy 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Spain 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Denmark 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Sweden 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Norway 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Asia-Pacific 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 China 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Japan 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 India 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Thailand 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 South Korea 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Australia 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Latin America 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Brazil 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Mexico 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc
  • Merck KGaA
  • PromoCell GmbH
  • Lonza
  • Corning Incorporated
  • Avantor, Inc.
  • Tecan Trading AG
  • REPROCELL Inc.
  • CN Bio Innovations Ltd.
  • Lena Biosciences

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.21 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

3D Cell Culture Market by Product, Application, End-User - Global Forecast 2025-2030 - Product Image

3D Cell Culture Market by Product, Application, End-User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
3D Cell Culture - Global Strategic Business Report - Product Image

3D Cell Culture - Global Strategic Business Report

  • Report
  • 150 Pages
  • Global
From
3D Cell Culture Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

3D Cell Culture Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
3D Cell Culture Technologies Global Market Report 2024 - Product Image

3D Cell Culture Technologies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
3D Cell Culture Market - Global Outlook & Forecast 2024-2029 - Product Image

3D Cell Culture Market - Global Outlook & Forecast 2024-2029

  • Report
  • 349 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.